Conceptio › Archive › ClinicalTrials.gov
ClinicalTrials.govpublic full text

Phase IIIb Study of Ribociclib + ET in Early Breast Cancer

Novartis Pharmaceuticals · 2024
ClinicalTrials.gov · Datasets · License: Public Domain · 2024
Open Source ↗
early breast cancer, hormone receptor positive (hr+), human epidermal growth factor receptor-2 negative (her2-), early breast cancer (ebc), premenopausal, postmenopausal, male breast cancer, ribociclib, lee011, endocrine therapy (et), interventional, phase3
This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Related documents

Record · ID 832870
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.